Mohamed Mabed

Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma

Mohamed Mabed, Loie Elhelw, Sameh Shamaa · British Journal of Cancer · 2004 · 61 citations · Full text

A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma

Mohamed Mabed, Mariwan Esmaeel, Tawfik Elkhodary et al. · European Journal of Cancer Care · 2009 · 40 citations

Thrombopoietin (TPO) Levels in Hepatic Patients with Thrombocytopenia

Salah Aref, Mohamed Mabed, Tarek Selim et al. · Hematology · 2004 · 33 citations · Full text

Urokinase Plasminogen Activator Receptor and Soluble Matrix Metalloproteinase-9 in Acute Myeloid Leukemia Patients: A Possible Relation to Disease Invasion

Salah Aref, M. El‐Sherbiny, Mohamed Mabed et al. · Hematology · 2003 · 30 citations

Hematological Malignancy, Disease Invasion, Urokinase Plasminogen Activator +15

The Interplay Between C-Myc Oncogene Expression and Circulating Vascular Endothelial Growth Factor (sVEGF), Its Antagonist Receptor, Soluble Flt-1 in Diffuse Large B Cell Lymphoma (DLBCL): Relationship to Patient Outcome

Salah Aref, Mohamed Mabed, K. Zalata et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 27 citations